This report summarises AI in Drug Discovery Market Analysis

The report covers the global market analysis of AI in DD with Forecast till 2030

The report covers the global market analysis of AI in DD with Forecast till 2029

This white paper is the product of a multidisciplinary team with collaboration across different areas and subject matter experts within AI in healthcare. Purpose of the Document is to introduce, define and clarify foundational topics, terms and concepts in AI with an emphasis on applications in healthcare, spanning the continuum from biomedical discovery, clinical development and patient care.

Data & Society Research Institute produces various reports exploring the social, cultural, and ethical implications of data-centric technologies.

Global Artificial Intelligence (AI) in Drug Discovery Market, By Application (Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug and Others), Technology (Machine Learning, Deep Learning, Natural Language Processing and Others), Drug Type (Small Molecule and Large Molecule), Offering (Software and Services), Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases and Others), End Use (Contract Research Organizations (CROs), Pharmaceutical & Biotechnology Companies, Research Centers and Academic Institutes and Others) Industry Trends and Forecast to 2029.

The Global Artificial Intelligence In Drug Discovery Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Published by the World Economic Forum, this annual report measures gender disparities in various countries across economic, political, educational, and health-related indicators.

Published by Open Knowledge Foundation, this report assesses and ranks countries based on the openness and accessibility of their government data.

The publication in the series on AI in Biopharma focuses on “Intelligent drug discovery” and showcases the impact that AI is making through a detailed review of 8 case studies. These case studies are from around the world and highlight the changing landscape of biopharma firms engaged in drug development; government and non-government interventions to drive AI-led discovery; and the growing importance of emerging markets in drug discovery.

This report assesses and ranks countries on their open data policies and practices, providing insights into the global state of open data.

This report by Mozilla Foundation examines the health of the internet, covering issues like privacy, security, and decentralization.